Table 1. Basic characteristics.
| Group 1 | Group 2 | Group 3 | p value | |
| Case number, n | 78 | 54 | 21 | - |
| Age, mean ± SD, y | 63.1 ± 11.5 | 59.5 ± 12.2 | 60.6 ± 12.2 | 0.22 |
| Hemoglobin, mean ± SD, g/dl | 13.9 ± 1.3 | 13.6 ± 1.8 | 13.6 ± 1.0 | 0.49 |
| GPT, mean ± SD, U/l | 25.9 ± 10.8 | 22.5 ± 9.8 | 25.8 ± 11.6 | 0.21 |
| Creatinine, mean ± SD, mg/dl | 0.8 ± 0.2 | 0.8 ± 0.2 | 0.9 ± 0.3 | 0.07 |
| Uric acid, mean ± SD, mg/dl | 5.8 ± 2.4 | 5.6 ± 1.5 | 5.4 ± 1.4 | 0.7 |
| Total cholesterol, mean ± SD, mg/dl | 186.3 ± 40.1 | 183.3 ± 36.8 | 179.8 ± 29.7 | 0.78 |
| LDL, mean ± SD, mg/dl | 108.7 ± 39.4 | 109.3 ± 29.5 | 100.9 ± 35.2 | 0.64 |
| LV ejection fraction, mean ± SD, % | 71.1 ± 6.9 | 70.2 ± 9.3 | 68.3 ± 7.8 | 0.36 |
| LV EDD, mean ± SD, mm | 44.9 ± 5.7 | 45.2 ± 5.1 | 45.9 ± 4.1 | 0.73 |
| LVESD, mean ± SD, mm | 26.3 ± 4.8 | 26.9 ± 5.4 | 28.2 ± 4.5 | 0.3 |
| Female gender, % | 0.436 | 0.426 | 0.571 | 0.29 |
| Hypertension, % | 0.577 | 0.5 | 0.714 | 0.24 |
| Diabetes, % | 0.208 | 9.6%* | 0.333 | 0.05 |
| ACEI/ARB, % | 0.39 | 0.308 | 0.524 | 0.22 |
| Beta blocker, % | 0.506 | 0.673 | 0.714 | 0.08 |
| Diuretics, % | 0.078 | 0.096 | 0.048 | 0.78 |
| Dihydropyridine CCB, % | 0.351 | 0.212 | 0.381 | 0.18 |
| Non-dihydropyridine CCB, % | 0.104 | 0.038 | 0 | 0.14 |
| Statin, % | 55.8%* | 0.308 | 0.381 | 0.02 |
ACEI, angiotensin-converting-enzyme inhibitor; ARB, angiotensin II receptor blocker; CCB, calcium channel blocker; EDD, end diastolic diameter; ESD, end systolic diameter; GPT, glutamic-pyruvic transaminase; LDL, low-density lipoprotein; LV, left ventricle; SD, standard deviation.